Quality indicators for cardiovascular disease prevention

The ESC has recently published quality indicators for cardiovascular disease prevention. These indicators are supported by evidence from the literature, underpinned by expert consensus and aligned with the 2021 ESC Guidelines on Cardiovascular Disease Prevention in Clinical Practice to offer a mechanism for the evaluation of ASCVD prevention care and outcomes. Noteworthy from an SCPRS perspective is that referral to cardiovascular rehabilitation after an acute event or an elective revascularization procedure is a main quality indicator for cardiovascular clinics which may improve uptake and outcome.

ACR, albumin creatinine ratio; APT, antiplatelet therapy; ASCVD, atherosclerosis cardiovascular disease; Ax, assessment; BP, blood pressure; CAC, coronary calcium scoring; CE, cardioembolic; CKD,chronic kidney disease; CR, cardiac rehabilitation; CV, cardiovascular; CVH, cardiovascular hospitalization; DM, diabetes mellitus; ECG, electrocardiogram; eGFR, estimated glomerular filtration rate; GLP-1 RA, glucagon-like peptide-1 receptor agonists; HbA1c, glycated haemoglobin; HBR, high bleeding risk; HTN, hypertension; LDL-C, low-density lipoprotein cholesterol; MDT, multidisciplinary team; MI, myocardial infarction; PAD, peripheral artery disease; PPI, proton pump inhibitors; PREMs, patient-reported experience measures; RAASi, renin–angiotensin–aldosterone system inhibitors; Rx, treatment; SGLT2i, sodium/glucose cotransporter-2 inhibitors; TTE, transthoracic echocardiogram

Link to publication doi: 10.1093/eurjpc/zwab160